Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.23 USD | -7.60% | -18.79% | -37.96% |
May. 16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.96% | 321M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Piper Sandler Assumes Replimune Group at Overweight With $44 Price Target